This article discusses the TTAB's decision in Bayer regarding how and when a foreign trademark can be used.
Related Professionals
-
Partner and National Co-Chair, Trademark/Copyright/Privacy Group+1.212.940.8554
-
Related Practices
Related Industries
Related Offices
Recent Articles
-
Explainer: the UK's NSI Act
December 22, 2025
-
Beyond borders 2025: the top five considerations on the road to success in cross-border life sciences M&A
December 18, 2025
-
Explainer: the UK's NSI Act
December 11, 2025